University of Queensland’s vaccine showing promising signs

Queensland’s coronavirus vaccine trial is showing promising signs, and appears to be ahead of schedule.

It comes after American pharmaceutical giant Pfizer reported their vaccine is now 90 percent effective after phase three of their trials.

The University of Queensland has also been working on a vaccine, and says they’re on track in their trials as well.


The jab is so far producing virus-neutralising antibodies, and is said to be showing a positive response in elderly patients.

UQ’s Professor Paul Griffin told The Today Show the two vaccines are quite different.

“They’re completely different technologies, the Pfizer vaccine is a MRNA vaccine, so it’s basically a blueprint for the antigen we want a response to that’s injected into people.

“This is a protein or a sub-unit vaccine, something that’s usually on the surface of the virus is made into the vaccine and that’s injected to get an immune response against the virus.

“So it’s typically a well trodden path, and typically a safe kind of vaccine, and it doesn’t have some of the storage issues we’ve seen with the Pfizer vaccine that requires that minus-80.

“This is a technology that we’re familiar with and it’s great to see that it appears to be working in this case as well,” Professor Griffin said.

There’s still no official timeline on when the Queensland vaccine will be available, with phase one of trials still underway.

The  Federal Health Minister Greg Hunt will tour UQ’s lab today.

Related article: Covid-19 vaccine deemed 90 percent effective, no serious side effects